Intersect ENT (XENT) Short Interest Ratio & Short Volume → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free XENT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Intersect ENT Short Interest DataCurrent Short Volume3,220,000 sharesPrevious Short Volume2,870,000 sharesChange Vs. Previous Month+12.20%Dollar Volume Sold Short$88.13 millionShort Interest Ratio / Days to Cover8.6Last Record DateApril 30, 2022Outstanding Shares33,814,000 sharesFloat Size33,060,000 sharesShort Percent of Float9.74%Today's Trading Volume14,512 sharesAverage Trading Volume351,526 sharesToday's Volume Vs. Average4% Short Selling Intersect ENT ? Sign up to receive the latest short interest report for Intersect ENT and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatXENT Short Interest Over TimeXENT Days to Cover Over TimeXENT Percentage of Float Shorted Over Time Ad Priority GoldThe 2024 Gold Rush: Unleashing Market PotentialWelcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights.Get your free information kit NOW, before it's too late. Intersect ENT Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20223,220,000 shares $88.13 million +12.2%9.7%8.6 $27.37 4/15/20222,870,000 shares $80.25 million +41.4%8.7%9.6 $27.96 3/31/20222,030,000 shares $56.86 million -21.6%6.1%8.1 $28.01 3/15/20222,590,000 shares $71.67 million +4.9%7.8%12.3 $27.67 2/28/20222,470,000 shares $67.18 million +7.9%7.6%12.2 $27.20 2/15/20222,290,000 shares $62.70 million +34.7%7.0%11.3 $27.38 Get the Latest News and Ratings for XENT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Intersect ENT and its competitors with MarketBeat's FREE daily newsletter. 1/31/20221,700,000 shares $46.58 million -8.1%5.2%8.1 $27.40 1/15/20221,850,000 shares $50.38 million +25.0%5.6%9.2 $27.23 12/31/20211,480,000 shares $40.42 million +2.8%4.5%7.3 $27.31 12/15/20211,440,000 shares $38.95 million -10.0%4.4%5.7 $27.05 11/30/20211,600,000 shares $42.83 million +5.3%4.9%6 $26.77 11/15/20211,520,000 shares $41.07 million +12.6%4.6%4.9 $27.02 10/29/20211,350,000 shares $36.41 million -5.6%4.2%3.1 $26.97 10/15/20211,430,000 shares $38.84 million No Change4.4%1.8 $27.16 9/30/20211,430,000 shares $38.90 million -3.4%4.4%1.7 $27.20 9/15/20211,480,000 shares $40.49 million -2.0%4.6%1.8 $27.36 8/31/20211,510,000 shares $41.09 million +11.0%4.7%1.9 $27.21 8/13/20211,360,000 shares $37.41 million -35.2%4.3%1.8 $27.51 7/30/20212,100,000 shares $49.04 million +94.4%6.6%3.3 $23.35 7/15/20211,080,000 shares $20.14 million +11.3%3.4%4.5 $18.65 6/30/2021970,200 shares $16.58 million -5.8%3.1%5.2 $17.09 6/15/20211,030,000 shares $17.56 million -1.0%3.3%6.4 $17.05 5/28/20211,040,000 shares $18.36 million +5.3%3.3%6 $17.65 5/14/2021987,300 shares $17.68 million +5.0%N/A5 $17.91 4/30/2021940,500 shares $21.20 million +2.4%N/A4.8 $22.54 4/15/2021918,400 shares $18.37 million +1.8%N/A4.7 $20.00 3/31/2021901,900 shares $17.66 million -8.5%2.9%4.4 $19.58 3/15/2021985,800 shares $22.08 million -6.1%3.2%4.3 $22.40 2/26/20211,050,000 shares $24.32 million +11.0%3.4%4.4 $23.16 2/12/2021946,100 shares $23.20 million -2.0%3.1%3.8 $24.52 1/29/2021965,600 shares $22.46 million -13.0%3.1%3.7 $23.26 1/15/20211,110,000 shares $27.75 million -4.3%3.6%4.1 $25.00 12/31/20201,160,000 shares $26.34 million -15.3%3.8%4.4 $22.71 12/15/20201,370,000 shares $29.81 million +13.2%4.4%5.1 $21.76 11/30/20201,210,000 shares $24.50 million -19.9%3.9%4.8 $20.25 10/30/20201,400,000 shares $21.84 million +34.6%4.5%5.8 $15.60 10/15/20201,040,000 shares $18.63 million +26.5%3.4%3.7 $17.91 9/30/2020822,200 shares $13.41 million -10.2%2.7%2.6 $16.31 9/15/2020915,300 shares $17.15 million -5.0%3.0%2.2 $18.74 8/31/2020963,200 shares $19.34 million -8.3%3.1%2.3 $20.08Trump’s “Tax Free” Retirement Strategy (Ad)Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… XENT Short Interest - Frequently Asked Questions What is Intersect ENT's current short interest? Short interest is the volume of Intersect ENT shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 3,220,000 shares of XENT short. 9.74% of Intersect ENT's shares are currently sold short. Learn More on Intersect ENT's current short interest. What is a good short interest ratio for Intersect ENT? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XENT shares currently have a short interest ratio of 9.0. Learn More on Intersect ENT's short interest ratio. What is a good short interest percentage for Intersect ENT? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.74% of Intersect ENT's floating shares are currently sold short. Is Intersect ENT's short interest increasing or decreasing? Intersect ENT saw a increase in short interest in April. As of April 30th, there was short interest totaling 3,220,000 shares, an increase of 12.2% from the previous total of 2,870,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Intersect ENT's float size? Intersect ENT currently has issued a total of 33,814,000 shares. Some of Intersect ENT's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Intersect ENT currently has a public float of 33,060,000 shares. How does Intersect ENT's short interest compare to its competitors? 9.74% of Intersect ENT's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Intersect ENT: Artivion, Inc. (7.16%), Paragon 28, Inc. (9.33%), AtriCure, Inc. (6.72%), MiMedx Group, Inc. (3.73%), OrthoPediatrics Corp. (6.10%), Silk Road Medical, Inc (10.50%), Atrion Co. (8.72%), Treace Medical Concepts, Inc. (6.39%), SI-BONE, Inc. (6.29%), Embecta Corp. (4.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Palo Alto Networks, Inc. ($4.31 billion), Charter Communications, Inc. ($3.24 billion), Lucid Group, Inc. ($2.25 billion), HP Inc. ($2.22 billion), GameStop Corp. ($1.69 billion), Carnival Co. & plc ($1.66 billion), Snap Inc. ($1.64 billion), Wayfair Inc. ($1.63 billion), Rivian Automotive, Inc. ($1.60 billion), and Upstart Holdings, Inc. ($1.53 billion). View all of the most shorted stocks. What does it mean to sell short Intersect ENT stock? Short selling XENT is an investing strategy that aims to generate trading profit from Intersect ENT as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Intersect ENT? A short squeeze for Intersect ENT occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XENT, which in turn drives the price of the stock up even further. How often is Intersect ENT's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XENT, twice per month. The most recent reporting period available is April, 30 2022. More Short Interest Resources from MarketBeat Related Companies: Artivion Short Squeeze Paragon 28 Short Squeeze AtriCure Short Squeeze MiMedx Group Short Squeeze OrthoPediatrics Short Squeeze Silk Road Medical Short Squeeze Atrion Short Squeeze Treace Medical Concepts Short Squeeze SI-BONE Short Squeeze Embecta Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XENT) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange